# Filana Therapeutics, Inc.: Form 8-K, filed Feb 19, 2026

- Company: [Filana Therapeutics, Inc.](/companies/flna.md) (CIK 1069530)
- Form: 8-K
- Filed: 2026-02-19
- Accepted by EDGAR: Feb 19, 2026, 08:15 ET
- Period: 2026-02-19
- Accession: 0001171843-26-000922
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1069530/000117184326000922/f8k_021926.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1069530/000117184326000922/

## Items reported

- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1069530/000117184326000922/f8k_021926.htm

Filed Feb 19, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-000922. Last ingested by Listed: Nov 13, 2026, 15:54 ET. No prices; not investment advice.
